Top 5 Safest Stocks To Buy For 2014

It seems that every day a new press release comes out about a big oil or gas discovery, and increasingly these announcements have one thing in common: All the finds are in offshore fields.

As offshore exploration and development increase, oilfield service companies are in high demand. In this video, Fool.com contributor Aimee Duffy talks to Tyler Crowe about how offshore production has affected oilfield service companies, and what investors can expect going forward.

National Oilwell Varco is perhaps the safest investment in the energy sector due to its industry-dominating market share. This company is poised to profit in a big way; its customers are both increasing the number of new drilling rigs and updating aging fleets of offshore rigs. To help determine whether it could be a good fit for your portfolio, you're invited to check out The Motley Fool's premium research report featuring in-depth analysis on whether NOV is a buy today. For instant access to this valuable investor's resource, simply click here now to claim your copy.

Hot Biotech Stocks To Own For 2015: Guggenheim S&P 500 Pure Growth ETF (RPG)

Rydex S&P 500 Pure Growth ETF (the Fund) seeks to replicate as closely as possible the performance of the S&P 500/Citigroup Pure Growth Index (the Index). The S Index is narrow in focus, containing only those S&P 500 companies with strong growth characteristics as selected by Standard & Poor��. The Index contains approximately one-third of the equities of the S&P 500 Index.

The Fund uses a passive management strategy to track the performance of the Index. The Fund invests in substantially all of the securities in the Index in approximately the same proportions as in the Index. The Fund's investment advisor is Rydex Investments.

Advisors' Opinion:

• [By John Udovich]

  Yesterday, small cap geothermal stock U.S. Geothermal Inc (NYSEMKT: HTM) produced a geyser of a return when it surged 26.79%, meaning its worth taking a closer look at the stock verses the performance of other geothermal stocks like small cap Ormat Technologies, Inc (NYSE: ORA) and mid cap Calpine Corporation (NYSE: CPN).�First of all, I should mention there are some other geothermal stocks out there like Alterra Power Corp (CVE: AXY) and Ram Power Corp (TSE: RPG) who have their primary listing on Canadian exchanges with secondary ones on the OTC���meaning they may not be a good deal for American investors or easy to invest in. Second, U.S. Geothermal Inc itself is a good geothermal proxy as its�focused on developing, owning, and operating clean, sustainable electric power from geothermal energy resources and its�operating geothermal power projects at Neal Hot Springs, Oregon; San Emidio, Nevada; and Raft River, Idaho plus El Ceibillo, an advanced stage, geothermal prospect located within a 24,710 acre energy rights concession area near Guatemala City, the largest city in Central America.

Top 5 Safest Stocks To Buy For 2014: Kawasaki Heavy Industries Ltd (KWHIY)

Kawasaki Heavy Industries Ltd (KHI), incorporated on October 15, 1896, is a global manufacturer of transportation equipment and industrial goods. KHI manufactures ships, rolling stock, aircraft and jet engines, gas turbine power generators, environmental and industrial plants, and range of manufacturing equipment and systems. KHI also produces consumer products, such as Kawasaki-brand motorcycles and personal watercraft. KHI�� business is divided into seven operations: shipbuilding, rolling stock and construction machinery, aerospace, gas turbines and machinery, plant and infrastructure engineering, consumer products and machinery, and hydraulic machinery.

Kawasaki Shipbuilding Corporation, which is the company of this segment, is engaged in building gas carriers and submarines, which require advanced design and construction technologies. It offers

a range of liquefied natural gas (LNG) carriers, extending from small carriers with cargo tank capacities of 19,000 cubic meters to large carriers with capacities of 177,000 cubic meters. It also developed and offered in its lineup a pressure build-up type LNG carrier for short distance and small-volume transportation. The Company�� shipbuilding operations include products, such as LNG carriers, liquefied petroleum gas (LPG) carriers, container ships, very large crude carriers (VLCCs) and other types of tankers, bulk carriers, high speed vessels, submarines, maritime application equipment.

KHI�� rolling stock production systems are located in Hyogo and Harima in Japan and in Lincoln, Nebraska, and Yonkers, New York, in United States. Kawasaki completed its light rail vehicle (LRV), dubbed SWIMO. It also is developing efSET (Environmentally Friendly Super Express Train) which achieves a service speed of 350 kilometers per hour (km/h). Regarding the construction machinery business, Kawasaki has arranged a business alliance with Hitachi Construction Machinery Co., Ltd., and TCM Corporation. As of April 1, 2009, the Compa! ny split off its construction machinery business as a wholly owned subsidiary of KHI, KCM Corporation.

KHI is the prime contractor for the development of the MOD�� large-scale XP-1 and C-X aircraft. In the commercial aircraft field, KHI delivered a test model of Boeing�� 787 Dreamliner passenger aircraft. KHI is a partner corporation in the development and production of the 787 Dreamliner.

The Gas Turbines & Machinery segment has a range of products for the energy and transportation equipment field. KHI focuses to expand its global business by offering solutions for its customers that include a lineup of in-house developed gas turbines together with product support and maintenance. During the year ended December 31, 2008, the 8MW-class power-generating capacity Kawasaki Green Gas Engine had 4,000 hours of operational testing.

The plant and infrastructure engineering segment encompasses the operations of Kawasaki Plant Systems, Ltd. (K Plant), which undertakes projects to supply energy-related, industrial infrastructure, environmental preservation systems and equipment, and the operations of the parent company�� Industrial Facilities and Tunneling Equipment Division, which mainly focuses on LNG tanks and diverse other storage tanks along with shield machines and tunnel-boring machines. The Anhui Conch Kawasaki Energy Conservation Equipment Manufacturing Co., Ltd. (CKM) is engaged in the manufacturing of PH boiler parts that are employed in waste heat power plants. CKM has commenced the manufacturing and sales of environmental preservation related products, including cement plant components, such as vertical mills, boilers for waste heat recovery power generation systems, and waste gasification systems and sewage treatment systems that can be integrated with cement kilns to enable municipal waste recycling.

The consumer products and machinery segment includes the manufacture of motorcycles, all terrain vehicles (ATVs), utility vehicles, personal! watercra! ft, general purpose gasoline engines and industrial robots. In the motorcycle line, Kawasaki launched the ZRX1200 DAEG and the Ninja ZX-6R. In the cruiser segment, Kawasaki launched its Vulcan 1700 series with developed engine and chassis. This series includes the Vulcan 1700 Voyager, a full-dress V-twin engine tourer with a load of long-distance touring equipment. In the utility vehicle category, KHI equipped the Teryx 750 series with an electronic fuel injection system, mainly for recreational use. The MULE utility-oriented vehicle series was restyled with the launch of the MULE 4010 series.

The hydraulic machinery operations include Kawasaki Precision Machinery Ltd. (KPM). It has five manufacturing and marketing facilities, which comprises KPM�� headquarters plant and the facilities

of Kawasaki Precision Machinery (U.K.) Limited; Kawasaki Precision Machinery (U.S.A.), Inc.; China based Kawasaki Precision Machinery (Suzhou) Ltd.; and Korea-based Flutek, Ltd.

Advisors' Opinion:

• [By WWW.MARKETWATCH.COM]

  LOS ANGELES (MarketWatch) -- Japanese stocks have ended with losses in every session this week, and sure enough, the Nikkei Average (JP:NIK) was down 0.6% in early Friday trade, though off an opening 0.8% defecit, while the Topix carried a 0.7% loss. Overnight losses for the U.S. and further strength in the yen (with the dollar falling to 楼101.28 from 楼101.56 a day earlier) helped drag the market lower, as did results from Fast Retailing Co. (JP:9983) (FRCOF) , the shares of which hold the heaviest weighting on Nikkei Average. Fast Retailing said that while its Uniqlo brand was doing great business, weakness for its J Brand luxury demin label helped send September-May profit down 4% and prompted another cut to Fast's full-year outlook. Consequently, its shares traded 0.7% lower, though rivals Takashimaya Co. (JP:8233) and J. Front Retailing Co. (JP:3086) (JFROF) also saw losses of 0.6% and 0.5%, respectively. Among other decliners, Sony Corp. (JP:6758) (SNE) lost 0.7%, Toshiba Corp. (JP:6502) (TOSYY) fell 2.1%, Kawasaki Heavy Industries Ltd. (JP:7012) (KWHIY) fell 1.5%, Toyota Motor Corp. (JP:7203) (TM) and Nissan Motor Co. (JP:7201)

Top 5 Safest Stocks To Buy For 2014: Medtronic Inc (MDT)

Medtronic, Inc. (Medtronic), incorporated on April 23, 1957, is engaged in medical technology - alleviating pain, restoring health, and extending life for millions of people worldwide. As of April, 27, 2012, the Company functions in two operating segments that manufacture and sells device-based medical therapies. The Company's operating segments include Cardiac and Vascular Group, which consists of Cardiac Rhythm Disease Management (CRDM) and CardioVascular, and Restorative Therapies Group, which consists of Spinal, Neuromodulation, Diabetes and Surgical Technologies. Medtronic serves hospitals, physicians, clinicians, and patients in more than 120 countries worldwide. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations. In August 2013, Medtronic, Inc. announced the closing of the acquisition of Cardiocom. Effective September 3, 2013, Medtronic Inc acquired a 30% stake in NGC Medical SpA.

Cardiac Rhythm Disease Management

CRDM develops, manufactures, and markets products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, including implantable devices, leads and delivery systems, products for the treatment of atrial fibrillation (AF), and information systems for the management of patients with CRDM devices. The Company's principal products offered by CRDM business include Implantable Cardiac Pacemakers (Pacemakers), Implantable Cardioverter Defibrillators (ICDs), Implantable Cardiac Resynchronization Therapy Devices (CRT-Ds and CRT-Ps), AF Products, Diagnostics and Monitoring Devices and Patient Management Tools. The Company's pacemaker systems are compatible with certain magnetic resonance imaging (MRI) machines. This includes the Revo MRI SureScan with United States Food and Drug Administration approval and the Advisa and Ensura MRI SureScan models with Conformite Europeene (CE)! Mark approval. Medtronic also continues to market the Adapta product family, which includes the Adapta, Versa, Sensia, and Relia models.

The Medtronic ICDs is the Protecta family with SmartShock technology, including the Lead Integrity Alert, a technology designed to improve the detection of lead fractures. Devices in the ICD family are the Protecta XT, Protecta, Cardia, and Egida models. Medtronic also continues to market the Secura and Maximo II devices. The Medtronic CRT-Ds is the Protecta family with SmartShock technology, including Protecta XT and Protecta, and the CRT-P devices are Consulta and Syncra. Medtronic also continues to market the Consulta, Cardia, Egida, and Maximo II CRT-D devices. In addition to these devices, Medtronic has an offering of left heart leads and delivery catheters with its Attain family of products. The Company's portfolio of AF products includes the Arctic Front Cardiac CryoAblation Catheter designed to treat paroxysmal AF by performing pulmonary vein isolation. The Company also offers the Reveal XT Insertable Cardiac Monitor, which is designed to identify and quantify episodes of AF. The Reveal DX and Reveal XT Insertable Cardiac Monitors devices are used to record the heart's electrical activity before, during, and after transient symptoms such as syncope and palpitations to help provide a diagnosis. It has a number of patient management tools, such as CareLink, Paceart, and CardioSight Service. CareLink enables patients to transmit data from their pacemaker, ICD, CRT-D, or Insertable Cardiac Monitors using a portable monitor that is connected to a standard telephone line or cellular network using the Medtronic M-Link accessory.

The Company competes with St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik, Inc. and Sorin Group.

CardioVascular

CardioVascular is comprised of three businesses: Coronary, Endovascular and Peripheral, and Structural Heart. The Coronary business includes therapies to treat ! coronary ! artery disease (CAD) and hypertension. The products contained within this business include coronary stents and related delivery systems, along with a broad line of balloon angioplasty catheters, guide catheters, guidewires, diagnostic catheters, and accessories. The products offered by its Coronary business include Percutaneous Coronary Intervention (PCI) and Renal Denervation. The Endovascular and Peripheral business is comprised of a range of products and therapies to treat abdominal and thoracic aortic aneurysms and peripheral vascular disease (PVD). The Company's products include endovascular stent graft systems, embolic protection systems, and stent systems for the treatment of narrowed iliac arteries. The products offered by the Company's Endovascular and Peripheral business include Endovascular Stent Grafts and Peripheral Vascular Intervention (PVI). The Structural Heart business offers a range of products and therapies to treat a variety of heart valve disorders. The Company's products include products for the repair and replacement of heart valves, perfusion systems, positioning and stabilization systems for beating heart revascularization surgery, and surgical ablation products. The Company's principal products offered by its Structural Heart business include Heart Valves, Transcatheter Heart Valves, Arrested Heart Surgery, Beating Heart Surgery and Surgical Ablation.

The Company competes with Abbott Laboratories, Boston Scientific, and Johnson & Johnson, Cook, Inc., W. L. Gore & Associates, Inc., Endologix, Inc., C.R. Bard, Inc., Edwards LifeSciences Corporation, St. Jude, Terumo Medical Corporation and Sorin Group.

Spinal

The Company's Spinal business develops, manufactures, and markets a range of medical devices and implants used in the treatment of the spine and musculoskeletal system. The Company's products and therapies treat a range of conditions affecting the spine, including degenerative disc disease, spinal deformity, spinal tumours, fractures ! of the sp! ine, and stenosis. The Company's Spinal business also provides biologic solutions for the dental and orthopedic markets. The Company's Spinal products are used in spinal fusion of both the thoracolumbar region, referring to the mid to lower vertebrae, as well as of the cervical region, or upper spine and neck vertebrae. Products used to treat spinal conditions include rods, pedicle screws, hooks, plates, and interbody devices, as well as biologics products, primarily bone growth substitutes including bone graft extenders and structural allografts such as dowels and wedges. The products offered by the Company's Spinal business include Thoracolumbar Products, Cervical Products and Biologics Products.

The Company competes with DePuy Spine, Inc., Synthes, Inc., Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Zimmer, Inc., Alphatec Spine, Inc., Orthofix International N.V., Biomet, Inc. and Johnson & Johnson.

Neuromodulation

The Company's Neuromodulation business develops, manufactures, and markets medical devices for the treatment of chronic pain, movement disorders, psychological disorders, and urological, fecal, and gastroenterological disorders. The l products offered by the Company's Neuromodulation business includes Neurostimulators for Chronic Pain, Implantable Drug Delivery Systems, Deep Brain Stimulation (DBS) Systems and Urology, Fecal, & Gastroenterology Devices. The Company's portfolio of products includes the RestoreSensor (rechargeable), with the Company's AdaptiveStim technology, as well as the RestoreULTRA (rechargeable), RestoreADVANCED (rechargeable), and PrimeADVANCED (non-rechargeable) neurostimulation systems. The SynchroMed II Programmable Infusion System delivers small quantities of drug directly into the intrathecal space surrounding the spinal cord. These devices are used to treat chronic, intractable pain and severe spasticity associated with cerebral palsy, multiple sclerosis, spinal cord and traumatic brain injuries, and stroke.

DBS uses a surgically implanted medical device, similar to a cardiac pacemaker, to deliver carefully controlled electrical stimulation to precisely targeted areas in the brain. The Company's family of Activa Neurostimulators for DBS includes Activa SC (single-channel primary cell), Activa PC (dual channel primary cell), and Activa RC (dual channel rechargeable). The Company's therapeutic portfolio for urology and gastroenterology includes the InterStim Therapy System, which treats the symptoms of overactive bladder, urinary retention, and chronic fecal incontinence, and the Enterra Therapy System for the treatment of chronic nausea and vomiting caused by gastroparesis of diabetic or idiopathic origin for drug refractory patients.

The Company's competes with Boston Scientific, St. Jude., Urologix, Inc. and Allergan.

Diabetes

The Company's Diabetes business develops, manufactures, and markets advanced, integrated diabetes management solutions that include insulin pump therapy, continuous glucose monitoring systems, and therapy management software. The products offered by the Company's Diabetes business includes Integrated Diabetes Management Solutions, Professional CGM and CareLink Therapy Management Software. Outside the United States, the Company offers its Paradigm Veo System, an integrated system that includes a Low Glucose Suspend feature that automatically suspends insulin delivery when glucose levels become too low. In the United States, the Company offers the Paradigm Revel System, which incorporates new CGM features, including predictive alerts that can give early warning to people with diabetes so they can take action to prevent dangerous high or low glucose events. Medtronic offers physicians a Professional CGM product called the iPro CGM and iPro2 Professional CGM. The Company offers Web-based therapy management software solutions, including CareLink Personal software for patients and CareLink Pro software, to helps patients and their health care prov! iders con! trol their diabetes.

The Company competes with DexCom, Inc., Insulet Corporation, Johnson & Johnson and Roche Ltd.

Surgical Technologies

The Company's Surgical Technologies business develops, manufactures, and markets products and therapies to treat diseases and conditions of the ear, nose, and throat (ENT) and certain neurological disorders. In addition, the business develops, manufactures, and markets image-guided surgery and intra-operative imaging systems that facilitate surgical planning during precision cranial, spinal, sinus, and orthopedic surgeries. The products offered by the Company's Surgical Technologies business includes ENT, Neurological Technologies, Navigation and Advanced Energy. The ENT products treat diseases and conditions, such as NIM Nerve Monitoring Systems, Fusion ENT Navigation System, Hydrodebrider Endoscopic Sinus Irrigation System, Meniett Device for Meniere's Disease, Pillar Procedure for Snoring and Sleep Apnea, and Repose System for Obstructive Sleep Apnea. The Neurological Technologies products treat certain neurological disorders and conditions, such as Midas Rex Spine Shaver, the Midas Rex MR7 Pneumatic Platform, the Midas Rex Legend EHS High Speed Surgical Drill, the Strata Family of Adjustable Valves for the treatment of Hydrocephalus, Duet External Drainage & Monitoring System, the IPC System, and the Subdural Evacuating Port System.

The Navigation products are used in cranial, spinal, sinus, and orthopedic surgeries, such as the StealthStation S7 Navigation and i7 Integrated Navigation Systems, the O-Arm 2D/3D Surgical Imaging System, and the PoleStar Surgical MRI System. The products make up the Advanced Energy business: PEAK Surgery System, a tissue dissection system that consists of the PEAK PlasmaBlade and the PULSAR Generator and is cleared for use in a variety of settings, including ENT, plastic reconstructive and general surgery; and the Aquamantys System, which uses patented Transcollation technology to ! provide h! aemostatic sealing of soft tissue and bone and is cleared for use in a range of surgical procedures, including orthopedic surgery, spine, solid organ resection and thoracic procedures.

The Company competes with Gyrus ACMI, Stryker Corporation, Johnson & Johnson, Integra LifeSciences Holdings Corporation, BrainLAB, Inc., GE Healthcare, Siemens Medical Solutions USA, Inc., Philips Medical Systems, Covidien and ArthroCare Corporation.

Advisors' Opinion:

• [By Dimitra DeFotis]

  Walgreen (WAG) stock is down 2.4%, despite speculation today that hospital products company�Hospira�(HSP) could bid for Danone�� medical-nutrition unit in what would be the latest so-called inversion deal — and a big one at possibly $5.1 billion. �Already in the works:�AbbVie�(ABBV) and�Medtronic�(MDT) are pursuing deals with�smaller Irish rivals that will permit the companies to switch their home base to Ireland.

Top 5 Safest Stocks To Buy For 2014: Danone SA (DANOY)

Danone SA, incorporated on February 2, 1899, is a France-based company engaged in food processing activities. The Company operates in four business lines, including Fresh Dairy Products, Waters, Baby Nutrition and Medical Nutrition. The Fresh Dairy Products business line�� brands are Danone, Actimel, Activia, Danacol and Vitalinea. The Water business line offers brands, such as Evian, Volvic, Aqua, Bonafont, Font Vella and Lanjaron. The Baby Nutrition business line include Bledina, Gallia, Nutricia, Cow & Gate, Milupa, Mellin and Dumex brands. Medical nutrition business includes Nutricia, Nutrini, Nutrison, Fortimel, FortiCare, Fortisip, Neocate and Infatrini brands. As of December 31, 2009, the Company acquired Danone Clover and a 26.85% interest in Micropharma. In December 2010, the Company and Unimilk announced the finalization of the merger of their Fresh Dairy Product businesses.

In Europe the Company�� main markets are France, Spain, Germany, Italy, the Benelux countries, the United Kingdom, Poland and Russia. The Company�� product Actimel, the probiotic dairy product, if consumed daily, helps to strengthen the organism�� natural defenses. The Waters business line includes activities focused on natural or flavored mineral water and on fruit-flavored or tea drinks, with a positioning concerned with health benefits. The Company�� baby nutrition business line�� activities consist mainly of producing food for newborns and babies (infant milk formula, follow-on milk, and growing up milk). It also offers a diverse range of products for

children aged 6 to 36 months. Specially developed and clinically tested formulas have also been developed for babies suffering from milk protein intolerance. The Medical Nutrition business line develops nutritional products adapted to specific needs, namely those of hospitalized patients, in order to prevent malnutrition and to improve its consumers daily life.

The Company competes with Nestle, PepsiCo, Coca-cola, Abbott, Mead! Johnson and Fresenius.

Advisors' Opinion:

• [By Jeff Reeves]

  Take the widely held Fidelity Worldwide Fund (FWWFX), which has 30% of its assets invested in Europe. Holdings include Swiss bank UBS (UBS), German automaker Volkswagen (VLKAY) and French food and consumer products giant Danone (DANOY).

• [By Tamara Rutter]

  Starbucks (NASDAQ: SBUX  ) ,�the world's most popular coffee chain, is joining forces with Danone� (NASDAQOTH: DANOY  ) to create an exclusive yogurt line called "Evolution Fresh, Inspired by Dannon."�The line of co-branded yogurts will be sold in U.S. Starbucks locations as soon as next year, and will reach grocery store shelves by 2015.